Tipifarnib in Treating Patients With Myelofibrosis and Myeloid Metaplasia - Related Studies

Tipifarnib in Treating Patients With Myelofibrosis and Myeloid Metaplasia

This study is ongoing, but not recruiting participants.

Study NCT00047190. Last updated on July 23, 2008. Information provided by National Cancer Institute (NCI)

Find Related Studies by Searching for the Conditions, Interventions, and Sponsors found in this study:


1	Additional conditions recognized in this trial
		Metaplasia
		Myelofibrosis
		Myeloid Metaplasia
		Myeloproliferative Disorders

2	More general conditions related to this trial
		Bone Marrow Diseases
		Hematologic Diseases
		Lymphatic Diseases
		Pathologic Processes
		Splenic Diseases

3	Interventions listed in this trial
		tipifarnib

4	More general drug interventions related to this trial
		Antineoplastic Agents
		Pharmacologic Actions
		Therapeutic Uses

5	Sponsors listed in this trial
		Mayo Clinic
		National Cancer Institute (NCI)